AGP Picks
View all

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on November 12, 2026

New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Battalion Oil Corporation Announces Third Quarter 2026 Financial and Operating Results
Gemini Reports Third Quarter 2026 Results
Future Technologies Expands Licensed Microwave Support to Help Cambium Legacy Customers Protect Network Investments
authID Reports Financial and Operating Results for the Third Quarter 2026
Xos Extends Gross Profit Streak, Highlighting Operational Efficiency
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates 
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2026
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Pyxis Tankers Agrees to Sell Pyxis Karteria at an Expected $21.0 Million Gain $37.0 million sale price expected to generate a gain of approximately $2.05 per share and support fleet expansion and renewal
InspireMD Announces Proposed Public Offering
BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Energous Wireless Power Solutions Reports Third Quarter 2026 Results
Voting Rights and Shares Capital of the Company
Information mensuelle relative au nombre total de droits de vote  et d’actions composant le capital social
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Chemicals Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.